Texas’ public colleges face a major overhaul that would shift more power over what’s taught and who’s hired to politically ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") today announced that analyses of the initial Phase 3 program of ampreloxetine (Studies 169 and 170) will be presented at the ...